{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:44:22Z","timestamp":1761241462132,"version":"build-2065373602"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Primary aldosteronism (PA) screening remains underdiagnosed at &lt;2% of eligible patients, with inconsistent interpretation of positive screening results across institutions. This study investigated whether patients with positive PA case screening test results received appropriate follow-up interventions. We assessed plasma renin activity (PRA) and aldosterone concentration (PAC), calculating the aldosterone-to-renin ratio (ARR). Three commonly used criteria defined positive case detection: PAC\u2009\u2265\u200910 ng\/dL and PRA\u2009&lt;\u20091 ng\/mL\/h; ARR\u2009\u2265\u200920 and PAC\u2009\u2265\u200910 ng\/dL; and ARR\u2009\u2265\u200930 and PAC\u2009\u2265\u200910 ng\/dL. We identified 237 patients meeting at least one criterion between April 2018 and May 2023, then assessed follow-up care at least 6 months post-screening. Adequate follow-up included documented abnormal results in progress notes, further PA diagnostics, new MRA treatment, or specialist referral. Inadequate follow-up was observed across all screening criteria: 37% (82\/222) of patients meeting PAC\u2009\u2265\u200910 ng\/dL and PRA\u2009&lt;\u20091 ng\/mL\/h, 38% (89\/237) of those meeting ARR\u2009\u2265\u200920 and PAC\u2009\u2265\u200910 ng\/dL, and 30% (53\/180) of those meeting ARR\u2009\u2265\u200930 and PAC\u2009\u2265\u200910 ng\/dL lacked appropriate care. History of hypokalemia (p\u2009&lt;\u20090.001), English as primary language (p\u2009\u2264\u20090.007), and higher socioeconomic status (p\u2009\u2264\u20090.06) were consistently associated with adequate follow-up. These findings highlight the need for standardized criteria and automated alerts to improve follow-up after positive PA screening.<\/jats:p>","DOI":"10.1371\/journal.pone.0333534","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:40:18Z","timestamp":1761241218000},"page":"e0333534","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Follow-up patterns after positive primary aldosteronism screening"],"prefix":"10.1371","volume":"20","author":[{"given":"Raul","family":"Herrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Kohlenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6787-5846","authenticated-orcid":true,"given":"Kidmealem","family":"Zekarias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"11","key":"pone.0333534.ref001","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"GP Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"pone.0333534.ref002","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis","volume":"101","author":"SC K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"pone.0333534.ref003","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice","volume":"69","author":"S Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pone.0333534.ref004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study","volume":"173","author":"JM Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"5","key":"pone.0333534.ref005","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"JW Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"pone.0333534.ref006","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"P Mulatero","year":"2020","journal-title":"J Hypertens"},{"issue":"9","key":"pone.0333534.ref007","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"TA Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"pone.0333534.ref008","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"P Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0333534.ref009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"S Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"pone.0333534.ref010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"GL Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"pone.0333534.ref011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"S Monticone","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"pone.0333534.ref012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-022-03084-x","article-title":"Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care","volume":"77","author":"J Ariens","year":"2022","journal-title":"Endocrine"},{"issue":"7","key":"pone.0333534.ref013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.eprac.2024.04.014","article-title":"Best Practice Alert to Promote Screening for Primary Aldosteronism Among People With Apparent Treatment-Resistant Hypertension","volume":"30","author":"KL Zekarias","year":"2024","journal-title":"Endocr Pract"},{"issue":"2","key":"pone.0333534.ref014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamainternmed.2023.7389","article-title":"Evaluation of a Best-Practice Advisory for Primary Aldosteronism Screening","volume":"184","author":"S Charoensri","year":"2024","journal-title":"JAMA Intern Med"},{"key":"pone.0333534.ref015","volume-title":"Introduction to the APA Guidelines for Psychological Practice for People with Low-Income and Economic Marginalization","author":"CL Juntunen","year":"2019"},{"issue":"1","key":"pone.0333534.ref016","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1186\/s12889-024-19049-w","article-title":"Estimating the causal effects of income on health: how researchers\u2019 definitions of \u201cincome\u201d matter","volume":"24","author":"E Igelstr\u00f6m","year":"2024","journal-title":"BMC Public Health"},{"issue":"22","key":"pone.0333534.ref017","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1001\/jama.294.22.2879","article-title":"Socioeconomic Status in Health Research: One Size Does Not Fit All","volume":"294","author":"PA Braveman","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"pone.0333534.ref018","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvac002","article-title":"International multicenter survey on screening and confirmatory testing in primary aldosteronism","volume":"188","author":"M Naruse","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"pone.0333534.ref019","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1472-6963-6-87","article-title":"Glucose testing and insufficient follow-up of abnormal results: a cohort study","volume":"6","author":"LM Kern","year":"2006","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0333534.ref020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diacare.27.1.9","article-title":"Opportunistic screening for diabetes in routine clinical practice","volume":"27","author":"MW Ealovega","year":"2004","journal-title":"Diabetes Care"},{"issue":"12","key":"pone.0333534.ref021","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archinternmed.2009.130","article-title":"Frequency of failure to inform patients of clinically significant outpatient test results","volume":"169","author":"LP Casalino","year":"2009","journal-title":"Arch Intern Med"},{"issue":"10","key":"pone.0333534.ref022","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s11606-011-1949-5","article-title":"Failure to follow-up test results for ambulatory patients: a systematic review","volume":"27","author":"JL Callen","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"2","key":"pone.0333534.ref023","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4338\/ACI-2015-10-RA-0135","article-title":"Workarounds and Test Results Follow-up in Electronic Health Record-Based Primary Care","volume":"7","author":"S Menon","year":"2016","journal-title":"Appl Clin Inform"},{"issue":"9","key":"pone.0333534.ref024","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline","volume":"110","author":"GK Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0333534.ref025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"P Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pone.0333534.ref026","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/a-1134-4980","article-title":"Hypokalemia and the Prevalence of Primary Aldosteronism","volume":"52","author":"S Gruber","year":"2020","journal-title":"Horm Metab Res"},{"issue":"4","key":"pone.0333534.ref027","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit","volume":"75","author":"J Burrello","year":"2020","journal-title":"Hypertension"},{"issue":"8","key":"pone.0333534.ref028","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajh\/hpad032","article-title":"Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low Renin and Hypertension","volume":"36","author":"A Mansur","year":"2023","journal-title":"Am J Hypertens"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:40:22Z","timestamp":1761241222000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333534"}},"subtitle":[],"editor":[{"given":"Mogamat-Yazied","family":"Chothia,","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333534","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}